[
  {
    "ts": "2025-02-24T12:32:00+00:00",
    "headline": "Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors",
    "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma CompleteTM, a circulating tumor DNA (ctDNA)-based comprehensive genomic profiling solution for patients with advanced solid tumors. The liquid biopsy test enables oncologists to perform comprehensive genomic profiling to inform personalized treatment decisions – all from a simple blood draw.",
    "url": "https://finance.yahoo.com/news/labcorp-announces-clinical-availability-liquid-123200458.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "5ef9b5d4-e9d8-3c2e-a70f-246de7b55712",
      "content": {
        "id": "5ef9b5d4-e9d8-3c2e-a70f-246de7b55712",
        "contentType": "STORY",
        "title": "Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors",
        "description": "",
        "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma CompleteTM, a circulating tumor DNA (ctDNA)-based comprehensive genomic profiling solution for patients with advanced solid tumors. The liquid biopsy test enables oncologists to perform comprehensive genomic profiling to inform personalized treatment decisions – all from a simple blood draw.",
        "pubDate": "2025-02-24T12:32:00Z",
        "displayTime": "2025-02-24T12:32:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/dfb2a169dcf74a375ce32bd7ba958549",
          "originalWidth": 400,
          "originalHeight": 107,
          "caption": "Labcorp Logo (PRNewsfoto/Labcorp)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SM3p35Xuy_wuoGOHdHaSIg--~B/aD0xMDc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/dfb2a169dcf74a375ce32bd7ba958549.cf.webp",
              "width": 400,
              "height": 107,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6eGa5lNZEUPNdJwS5YYjyg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/dfb2a169dcf74a375ce32bd7ba958549.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/labcorp-announces-clinical-availability-liquid-123200458.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/labcorp-announces-clinical-availability-liquid-123200458.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]